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Background
Human noroviruses are a major cause of epidemic and
sporadic gastroenteritis worldwide and can chronically
infect immunocompromised patients. Efforts to develop
effective vaccines and antivirals have been hindered by the
uncultivable nature and extreme genetic diversity of
human noroviruses [1]. Previous therapies have focused
on targeting nucleases and structural proteins. The noro-
virus RNA genome or viral transcripts also constitute an
important target to inhibit the replication of norovirus.
Finding a conserved component of the Norovirus genome
would make it an ideal target that could overcome the
genetic diversity of strains [2].
Gene-based therapy is the intentional modulation of
gene expression in specific cells to treat pathological con-
ditions. This modulation is accomplished by introducing
exogenous nucleic acids such as small interfering RNA
(siRNA). Given the large size and negative charge of this
macromolecule, its delivery is typically mediated by car-
riers or vectors. Targeting the gastrointestinal (GI) tract
represents a promising strategy for local or systemic deliv-
ery of gene-based therapeutics [3].
Methods
A common Norovirus Genotype to the Irish population
was identified. Conserved components of the Norovirus
genome were isolated for targeted antiviral therapy.
BLAST searches and homology searches were conducted
on these sequences identified.
A Literature review was conducted on siRNA-mediated
inhibition techniques and its application to the gastroin-
testinal tract. A review was also conducted on the recent
advances in material sciences, nanotechnology and nucleic
acid chemistry that have yielded promising non-viral deliv-
ery systems.
Results
The Sydney 2012 genotype was found to be the most pre-
valent virus strain in Ireland and the RNA dependant
RNA polymerase (RdRp) was found to be a conserved
component. Two candidate sequences of the RdRP were
identified for siRNA mediated inhibition.
Conclusions
The development of a Nano-carrier for siRNA delivery via
the GI tract would enable localised therapy for Norovirus.
Gene therapy via this route has many advantages, includ-
ing non-invasive access and the versatility to treat local
diseases, such as Norovirus. However, the intestine
presents several distinct barriers and, therefore, the design
of robust non-viral delivery systems is key to future suc-
cess. Several non-viral delivery strategies have provided
evidence of activity in vivo [4,5]. This report reviews
the possibility of siRNA-mediated inhibition of the RNA
norovirus genome and the challenges that an oral
gastrointestinal-delivery system will face.
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